Ashish M. Kamat, MD, MBBS

Endowed Professor, Surgeon, Former Fellowship Director @UTMDAnderson | President @IBCG_BladderCa | Assoc Editor @EurUrolOncol | Views my own

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

@shilpaonc @IBCG_BladderCA @montypal @UrogerliMD @neerajaiims @SpiessPhilippe @AndreaNecchi @PGrivasMDPhD @WorldBladderCan Thank you for those very kind words, Shilpa!

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

@MargoWickersham 🙏💕🙏

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

A lovely and unexpected recognition and honor to be ranked #1

Grateful to the many outstanding colleagues and collaborators who have made this work possible over the years.

Science is always a team effort. Thank you, @UrologyWatchHQ! #BladderCancer

[UrologyWatch.com @UrologyWatchHQ]

#1 in bladder cancer on Urology Scholars: @urodocash of @UTMDAnderson, with 388 bladder cancer papers on PubMed (582 in urology, #11 overall). A career shaping how we treat #bladdercancer, including as President of @IBCG_BladderCa.

See the full top 20:
https://t.co/8Vj60tlom0

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

@jteoh_hk @CUHKMedicine @DocGauhar @paolo_gontero @LauraBukavinaMD @DrMihirDesai @MaxKates @LiMingSu1 @JoshMeeks @Agarwal_CaB @Adam_Weiner535 @RoboDuke1 Congratulations Jeremy!

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

I might be biased, having directed our Urologic Oncology Fellowship from 2005–2016, but I’ve always believed it’s one of the finest training programs for #UroOnc!

It got even better under @ChapinMD, and is now poised for greater heights with @KKBree at the helm!

Come meet our team and see for yourself. @SUO_YUO #OncSurgery @UTMDAnderson

[OncoDaily @oncodaily]

Marking 10 Years of the Endowed Professorship in Cancer Research at UT MD Anderson - Ashish Kamat

@UroDocAsh

https://t.co/D8Qb4SWQdu

[UroToday.com @urotoday]

Healthcare utilization and costs of blue light versus white light cystoscopy in #BladderCancer. @MarkTysonMD @MayoClinic joins @UroDocAsh @UTMDAnderson to present a retrospective claims study comparing blue light and white light cystoscopy using the Optum Research Database from 2011 to 2023. #WatchNow on UroToday > https://t.co/ihAMvIjqoP

[OncUpdates @OncUpdates]

⭐️ #ESMO26 |🔑 Advances

✅Durva + neoadjuvant EV→EFS +OS benefit in cis-ineligible MIBC
✅Earlier ARPI intensification ⬆️ MFS in high-risk prostate ca
✅Adjuvant pembro OS benefit in high-risk RCC

#gucsm #OncTwitter @OncBrothers @shilpaonc @UroDocAsh
https://t.co/CxFcsj1f2v

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

@shilpaonc @neerajaiims @montypal @BrainTumorDoc @VivekSubbiah @scserendipity1 @JasmineKambojMD @OncBrothers @VedangMurthy @drgaganprakash 🙏

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Happy Diwali to friends and family around the world! 🪔

Wishing you good health, happiness, and time with the people who matter most. May the year ahead bring light, laughter, and plenty of reasons to celebrate!

#HappyDiwali #HappyDiwali2026

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

@OncBrothers @BijoyTelivala @RenoHemonc @NVijayvergiaMD @neerajaiims @UGrewalMD @GKaurMD @SuyogCancer @CharuAggarwalMD @rutikamehtaMD 🙏

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Happy Diwali to friends and family around the world! 🪔

Wishing you good health, happiness, and time with the people who matter most. May the year ahead bring light, laughter, and plenty of reasons to celebrate!

#HappyDiwali #HappyDiwali2026

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

@RRGonzalezMD @HMethodistUro @HMethodistMD @bsc_urology @Zach_Kahlenberg @hazemelmansy1 Congratulations!!

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Happy Diwali to friends and family around the world! 🪔

Wishing you good health, happiness, and time with the people who matter most. May the year ahead bring light, laughter, and plenty of reasons to celebrate!

#HappyDiwali #HappyDiwali2026

[Simon C @scserendipity1]

Go Team India! 🇮🇳🇮🇳🇮🇳🇮🇳

Thank you Ashish ✨

On the weekend of Diwali! The festival of lights. 🪔🪔🪔🪔

My 🇮🇳 father would always say Diwali brings knowledge over ignorance (anything to get me to do my homework!)

How appropriate for Team India to be educating us on low dose immunotherapy and how to make cancer care more accessible, truly a victory of light over darkness!

Well done Shilpa and Aditya!

Go Team India! And let’s increase Aditya’s following, like Shilpa he brings the knowledge and the light!

Thank you Brian and Tom!

@OpenMedKate @DrShubhamPant @DrRiyazShah @VedangMurthy @TylerSbrt
@shiv_smith @SimonMDLord @OncBrothers
@brookmans76 @OpenMedInsights

[Shilpa Gupta, MD, FASCO @shilpaonc]

Thanks @OncBrothers for a fun and insightful discussion with @UroDocAsh and me on the latest GU cancer updates from @myESMO! Always great to exchange perspectives on practice changing data and what the update and implications will be in real world!

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Chai Pe Charcha, with a competitive twist! ☕🇮🇳

Some friendly rivalry, and plenty of banter!

Go Team India! 🏆 @shilpaonc @montypal @VivekSubbiah @neerajaiims and the honorary Indian: @PGrivasMDPhD

[Uromigos @Uromigos]

🇮🇳 Team India is brewing up some competition at the Uromigos World Cup! ☕⚽🏆

It's Chai Pe Charcha time! From Mumbai to Cleveland, Team India is exploring whether low-dose immunotherapy could make cancer treatment more affordable and what it might mean for bladder cancer.

Cheers to the competition! ☕

🎥 : @shilpaonc & @adidhanawat | #UromigosLive

[Bladder Cancer Advocacy Network @BladderCancerUS]

@JoshMeeks and @UroDocAsh discuss de-escalation of therapy in MIBC and Metastatic Bladder Cancer After EV-Pembrolizumab and BCAN's Think Tank 2026: https://t.co/esbkDOsKnm

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Hard to believe it has been 10 years! Having the “Wayne B. Duddlesten, Sr. Professorship in Cancer Research in Honor of Dr. Ashish M. Kamat” established at @UTMDAnderson remains one of the greatest honors of my career.

Having an endowed professorship bear both our names is especially meaningful given the friendship Wayne and I shared.

Forever grateful. #OncSurgery

[UroToday.com @urotoday]

JCOG1019 Trial: Active Surveillance Versus BCG for T1 Bladder Cancer with Negative Second TUR.
Can BCG be skipped in high-grade T1 #BladderCancer after a negative second TUR? @hiroshi_dko
joins @UroDocAsh to discuss JCOG1019: surveillance was non-inferior to BCG. #WatchNow > https://t.co/Rauqo2BzSr

[UroToday.com @urotoday]

Patient perspectives on the meaning of response after systemic therapy for #BladderCancer.
What does "response" mean to a patient? #BladderCancer advocates Rick Bangs @BladderCancerUS and @MargoWickersham join @shilpaonc @ClevelandClinic to discuss how bladder cancer patients interpret treatment response terminology at #IBCG2026, noting that patients often hear "complete response" as cancer gone for good, not a snapshot requiring ongoing discussion. #WatchNow > https://t.co/BuTm11tvOx #IBCG26 @IBCG_BladderCA @UroDocAsh

[Oncology Brothers @OncBrothers]

We touched on 5 🔑 studies during our GU Malignancies Highlights from #ESMO26 w/ @shilpaonc & @UroDocAsh

⭐️ #VOLGA
⭐ #DASLHICaP & #PROTEUS
⭐ #KEYNOTE564
⭐ #LITESPARK022

#OncTwitter #gusm @OncUpdates @myESMO